Stay updated on Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:36:41.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Administrative update: Revision v3.4.2 was added and the previous operating-status notice (rev. 3.4.1) was removed; there is no change to the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:46:09.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and a version update (Revision: v3.4.1) were added, while Revision: v3.4.0 was removed; no substantive study content changes are indicated. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:14:04.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary information is now shown on the page. The footer metadata has been updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision note 'v3.4.0' (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T06:09:38.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, a minor metadata change that does not affect the displayed study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:30:39.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a new Locations section with Texas as a listed site. Removed the old Texas Locations heading and the HHS Vulnerability Disclosure footer link; the page revision will now show as v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:09:22.000Z thumbnail image

Stay in the know with updates to Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.